Schroder Investment Management Group boosted its holdings in Chemours Company (The) (NYSE:CC) by 536.6% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 26,100 shares of the specialty chemicals company’s stock after acquiring an additional 22,000 shares during the period. Schroder Investment Management Group’s holdings in Chemours Company (The) were worth $927,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of CC. BlackRock Inc. raised its holdings in shares of Chemours Company (The) by 48,297.2% during the first quarter. BlackRock Inc. now owns 19,160,930 shares of the specialty chemicals company’s stock valued at $737,696,000 after buying an additional 19,121,339 shares during the last quarter. FMR LLC raised its holdings in shares of Chemours Company (The) by 36.6% during the first quarter. FMR LLC now owns 14,925,373 shares of the specialty chemicals company’s stock valued at $574,627,000 after buying an additional 3,998,914 shares during the last quarter. Renaissance Technologies LLC raised its holdings in shares of Chemours Company (The) by 135.9% during the first quarter. Renaissance Technologies LLC now owns 3,031,400 shares of the specialty chemicals company’s stock valued at $116,709,000 after buying an additional 1,746,100 shares during the last quarter. State Street Corp raised its holdings in shares of Chemours Company (The) by 35.1% during the first quarter. State Street Corp now owns 5,791,792 shares of the specialty chemicals company’s stock valued at $222,987,000 after buying an additional 1,504,657 shares during the last quarter. Finally, Sirios Capital Management L P bought a new stake in shares of Chemours Company (The) during the second quarter valued at approximately $37,430,000. 72.90% of the stock is currently owned by hedge funds and other institutional investors.

A number of equities research analysts have recently weighed in on CC shares. Citigroup Inc. raised Chemours Company (The) from a “neutral” rating to a “buy” rating and lifted their price target for the company from $43.00 to $45.00 in a report on Wednesday, July 5th. Jefferies Group LLC reaffirmed a “buy” rating and set a $48.00 price target on shares of Chemours Company (The) in a report on Friday, June 16th. BidaskClub raised Chemours Company (The) from a “hold” rating to a “buy” rating in a report on Wednesday, July 12th. J P Morgan Chase & Co lifted their price target on Chemours Company (The) to $55.00 and gave the company an “overweight” rating in a report on Friday, August 4th. Finally, Zacks Investment Research cut Chemours Company (The) from a “buy” rating to a “hold” rating in a report on Wednesday, July 12th. Two equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $51.50.

Shares of Chemours Company (NYSE:CC) opened at 51.79 on Monday. The stock’s 50 day moving average price is $50.42 and its 200-day moving average price is $50.42. Chemours Company has a 12-month low of $14.41 and a 12-month high of $52.15. The company has a market cap of $9.57 billion, a PE ratio of 33.89 and a beta of 3.64.

Chemours Company (The) (NYSE:CC) last issued its quarterly earnings data on Wednesday, August 2nd. The specialty chemicals company reported $0.87 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.85 by $0.02. The firm had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.49 billion. Chemours Company (The) had a net margin of 4.96% and a return on equity of 122.97%. The company’s quarterly revenue was up 14.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.27 earnings per share. On average, equities research analysts forecast that Chemours Company will post $3.51 earnings per share for the current year.

The business also recently announced a quarterly dividend, which was paid on Friday, September 15th. Stockholders of record on Thursday, August 17th were given a dividend of $0.03 per share. The ex-dividend date of this dividend was Tuesday, August 15th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.23%. Chemours Company (The)’s payout ratio is 8.11%.

ILLEGAL ACTIVITY NOTICE: “Schroder Investment Management Group Acquires 22,000 Shares of Chemours Company (The) (CC)” was originally published by Daily Political and is the sole property of of Daily Political. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of international copyright & trademark laws. The original version of this piece of content can be accessed at https://www.dailypolitical.com/2017/09/25/schroder-investment-management-group-acquires-22000-shares-of-chemours-company-the-cc.html.

In other news, insider E Bryan Snell sold 10,000 shares of the company’s stock in a transaction that occurred on Friday, August 11th. The shares were sold at an average price of $46.24, for a total transaction of $462,400.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Amy Trojanowski sold 2,500 shares of the company’s stock in a transaction that occurred on Friday, August 11th. The stock was sold at an average price of $46.03, for a total transaction of $115,075.00. The disclosure for this sale can be found here. Insiders have sold 38,837 shares of company stock worth $1,865,603 over the last quarter. 1.14% of the stock is owned by company insiders.

About Chemours Company (The)

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins.

Institutional Ownership by Quarter for Chemours Company (The) (NYSE:CC)

Receive News & Ratings for Chemours Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.